Design Therapeutics
DSGN
DSGN
117 hedge funds and large institutions have $358M invested in Design Therapeutics in 2025 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 39 increasing their positions, 28 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
23% more funds holding
Funds holding: 95 → 117 (+22)
6.35% more ownership
Funds ownership: 60.57% → 66.92% (+6.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
117
Holding in Top 10
2
Calls
$4.7M
Puts
$102K
Top Buyers
| 1 | +$15.9M | |
| 2 | +$12.6M | |
| 3 | +$7.72M | |
| 4 |
Morgan Stanley
New York
|
+$4.12M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$4.07M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$11.2M | |
| 3 | -$9.04M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$4.18M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$1.92M |
